gene and protein altering methodologies

ARIZ Precision Medicine is a preclinical stage biopharmaceutical company in Davis, California, developing precision ligand targeted siRNA cancer therapies. It combines biological and nanotechnologies to target the genetic and epigenetic drivers of cancer, aiming to destroy cancer cells without harming normal cells. Its proof of principle studies showed selective killing of multiple cancer cell types including breast, colon, lung, and myeloma.

Read more

drug designnanotechnology drug deliverypreclinical animal model testing